Alterity Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$469K Sell
1,628
-25
-2% -$6.81K 0.67% 44
2023
Q3
$444K Hold
1,653
0.7% 41
2023
Q2
$367K Sell
1,653
-122
-7% -$28.3K 0.53% 49
2023
Q1
$429K Hold
1,775
0.63% 42
2022
Q4
$466K Sell
1,775
-200
-10% -$53.6K 0.76% 41
2022
Q3
$445K Sell
1,975
-150
-7% -$36.4K 0.72% 40
2022
Q2
$517K Buy
+2,125
New +$521K 0.77% 40
2021
Q4
$484K Buy
+2,150
New +$454K 0.52% 54
2021
Q1
$514K Buy
+2,125
New +$507K 0.62% 48

Other funds holding AMGN

Alterity Financial Group's AMGN Position: Q4 2023 in Review

Alterity Financial Group reduced its Amgen (AMGN) stake by 1.5% in Q4 2023, selling an estimated $6.81K and leaving 1,628 shares worth $469K. The position accounts for 0.67% of the portfolio, ranked #44.

Alterity Financial Group first reported a position in AMGN in Q1 2021 and has held it in 9 quarters since. The position peaked at $517K in Q2 2022. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Alterity Financial Group held 1,628 shares of Amgen worth $469K as of Q4 2023.
  • Alterity Financial Group sold 25 Amgen shares in Q4 2023, an estimated $6.81K.
  • Amgen made up 0.67% of Alterity Financial Group's portfolio in Q4 2023, its #44 holding.
  • Alterity Financial Group first reported a position in Amgen in Q1 2021 and has held it in 9 quarters since.
  • Alterity Financial Group's Amgen position peaked at $517K in Q2 2022.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Alterity Financial Group's 13F filing for Q4 2023, filed 18 Jan 2024.